LEO Pharma enhances dermatology pipeline with Timber Pharmaceuticals takeover
LEO Pharma has acquired Timber Pharmaceuticals, in a deal that will add an ‘attractive’ late stage asset to its pipeline in medical dermatology, the company said.
Archives for August 22, 2023
Janssen granted additional European Commission approval for bispecific antibody
Janssen, a Johnson & Johnson company, has announced that its bispecific antibody has been granted approval by the European Commission (EC) for use in certain patients with relapsed or refractory multiple myeloma (RRMM).
Actimed secures extra £4.75M funding towards 'first globally approved product' treating cancer cachexia
Actimed Therapeutics Ltd will put some of its additional funding of £4.75 million ($6 million) towards its attempt to provide the world’s first cure for cancer cachexia.